MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3389/fmicb.2026.1767720

Медицинская библиотека · Frontiers in microbiology · 2026

Aerosol inhalation of human IFN-α1b exhibits anti-RSV activity in mice and favorable pharmacokinetics/safety in cynomolgus monkeys.

Yang Mingming, Guo Liping, Wang Yanran, Bai Jiangtao, Liang Xiaowen, Kuang Jiahua, Ma Hongjie, Yang Yang

СтатьяПеревод пока не подготовлен

Аннотация

INTRODUCTION

Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infections, while effective therapeutic options remain limited. This study investigated the antiviral efficacy, pharmacokinetics, and safety of aerosolized human interferon-α1b (IFN-α1b) as a potential treatment for RSV infection.

METHODS

The antiviral activity of IFN-α1b against RSV was evaluated in vitro and in an RSV-infected mouse model. Pharmacokinetics, tissue distribution, and repeat-dose inhalation toxicity were assessed in cynomolgus monkeys.

RESULTS

IFN-α1b inhibited RSV in vitro (EC₅₀ of 4.64 ng/mL). In mice, aerosolized IFN-α1b reduced lung viral titers in a dose-dependent manner. Notably, the reduction in viral load across all IFN-α1b dose groups was greater than that observed in the ribavirin-treated group under the conditions tested (p < 0.001). In monkeys, inhalation resulted in high respiratory drug exposure with an absolute systemic bioavailability of 3.33%. Repeated dosing (18 μg/kg/day) was well tolerated, with only minimal to mild (Grade 1 to 2) focal lung inflammation that was fully reversible.

CONCLUSION

Aerosolized IFN-α1b demonstrates antiviral activity and favorable lung-targeted pharmacokinetics in preclinical models, supporting further investigation in clinical settings. It was associated with greater reduction in lung viral titers compared with ribavirin in this model while maintaining a favorable safety profile.

Для цитирования: Yang Mingming, Guo Liping, Wang Yanran, Bai Jiangtao, Liang Xiaowen, Kuang Jiahua, Ma Hongjie, Yang Yang. Aerosol inhalation of human IFN-α1b exhibits anti-RSV activity in mice and favorable pharmacokinetics/safety in cynomolgus monkeys.. Frontiers in microbiology. 2026. DOI: 10.3389/fmicb.2026.1767720.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.